Article
Periostin, a novel biomarker of TH2-driven asthma.
Current opinion in pulmonary medicine - 1 Jan 2014
Parulekar Amit D, Atik Mustafa A, Hanania Nicola A
Abstract excerpt
PURPOSE OF REVIEW: Asthma is a heterogeneous disease with multiple, overlapping phenotypes. Biomarkers are currently being investigated to better characterize the disease phenotypes and to identify the responders to specific targeted therapies. This review focuses on the emerging data surrounding the use of one such biomarker for T helper 2 (TH2)-driven asthma: periostin. RECENT FINDINGS: Periostin is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
